Lack of access to medicine is a major driver of drug resistance. How can pharma take action?

  10 June 2022

The antibiotic market is unstable, with fragile supply chains and tough market conditions. This report sets out how these factors limit the development of a robust go-to-market model for such products. It features six case studies where companies and their partners are using a combination of access strategies to cut through the complexity and address access at a local level.

Download the report directly

 

Author(s): Access to Medicine Foundation
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!